six generic manufacturers Deal History & Licensing Activity
six generic manufacturers is a life sciences. Over the past three years, six generic manufacturers has been involved in 3 licensing and acquisition transactions, with a primary focus on Small Molecules (4 deals).
Deals (12mo)
4
Active Trials
0
Top Modality
Small Molecules
Focus Area
Infectious Disease
six generic manufacturers Recent Deal Activity
Licensing, acquisition, and partnership transactions involving six generic manufacturers in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Lenacapavir | generic manufacturers | Small Molecules | Approved | license | Jun 2025 |
six generic manufacturers Pipeline Focus
Therapeutic areas and modalities where six generic manufacturers is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches six generic manufacturers's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About six generic manufacturers Licensing & Deal Activity
six generic manufacturers is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, six generic manufacturers ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for six generic manufacturers include Infectious Disease (4 deals and trials). In terms of modality, six generic manufacturers has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for six generic manufacturers and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against six generic manufacturers's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.